These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 27320548

  • 1. D-MELD, the Product of Donor Age and Preoperative MELD, Predicts Surgical Outcomes After Living Donor Liver Transplantation, Especially in the Recipients With HCV-positive and Smaller Grafts.
    Tanemura A, Mizuno S, Kato H, Murata Y, Kuriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Isaji S.
    Transplant Proc; 2016 May; 48(4):1025-31. PubMed ID: 27320548
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. D-MELD as a predictor of early graft mortality in adult-to-adult living-donor liver transplantation.
    Ikegami T, Imai D, Wang H, Yoshizumi T, Yamashita Y, Ninomiya M, Iguchi T, Bekki Y, Shirabe K, Maehara Y.
    Transplantation; 2014 Feb 27; 97(4):457-62. PubMed ID: 24531822
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
    Chok KS, Fung JY, Chan AC, Dai WC, Sharr WW, Cheung TT, Chan SC, Lo CM.
    Ann Surg; 2017 Jan 27; 265(1):173-177. PubMed ID: 28009743
    [Abstract] [Full Text] [Related]

  • 6. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF.
    Liver Transpl; 2003 Jul 27; 9(7):737-40. PubMed ID: 12827562
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. High MELD score does not adversely affect outcome of living donor liver transplantation: Experience in 1000 recipients.
    Yadav SK, Saraf N, Saigal S, Choudhary NS, Goja S, Rastogi A, Bhangui P, Soin AS.
    Clin Transplant; 2017 Aug 27; 31(8):. PubMed ID: 28497523
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Live donor liver transplantation in high MELD score recipients.
    Selzner M, Kashfi A, Cattral MS, Selzner N, McGilvray ID, Greig PD, Levy GA, Renner EL, Grant DR.
    Ann Surg; 2010 Jan 27; 251(1):153-7. PubMed ID: 19858705
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.
    Jain A, Singhal A, Kashyap R, Safadjou S, Ryan CK, Orloff MS.
    Transplantation; 2011 Aug 27; 92(4):453-60. PubMed ID: 21799468
    [Abstract] [Full Text] [Related]

  • 14. Adult-to-adult right-lobe living donor liver transplantation in recipients with hepatitis B virus-related benign liver disease and high model end-stage liver disease scores.
    Jiang L, Yan L, Tan Y, Li B, Wen T, Yang J, Zhao J.
    Surg Today; 2013 Sep 27; 43(9):1039-48. PubMed ID: 23467980
    [Abstract] [Full Text] [Related]

  • 15. Results of liver transplantation from old donors.
    Dudek K, Kornasiewicz O, Remiszewski P, Zieniewicz K, Wróblewski T, Krawczyk M.
    Transplant Proc; 2014 Oct 27; 46(8):2762-5. PubMed ID: 25380912
    [Abstract] [Full Text] [Related]

  • 16. Is Muscle MELD a More Promising Predictor for Mortality After Living Donor Liver Transplantation?
    Badawy A, Kaido T, Hamaguchi Y, Anazawa T, Yagi S, Fukumitsu K, Kamo N, Okajima H, Uemoto S.
    Prog Transplant; 2018 Sep 27; 28(3):213-219. PubMed ID: 29902957
    [Abstract] [Full Text] [Related]

  • 17. Comparison of Different Scoring Systems Based on Both Donor and Recipient Characteristics for Predicting Outcome after Living Donor Liver Transplantation.
    Ma Y, Wang Q, Yang J, Yan L.
    PLoS One; 2015 Sep 27; 10(9):e0136604. PubMed ID: 26378786
    [Abstract] [Full Text] [Related]

  • 18. Survival after live donor versus deceased donor liver transplantation: propensity score-matched study.
    Kaltenmeier C, Liu H, Zhang X, Ganoza A, Crane A, Powers C, Gunabushanam V, Behari J, Molinari M.
    BJS Open; 2024 May 08; 8(3):. PubMed ID: 38837956
    [Abstract] [Full Text] [Related]

  • 19. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD, Goldberg DS, Goodrich NP, Lok AS, Verna EC, Selzner N, Stravitz RT, Merion RM.
    Liver Transpl; 2016 Sep 08; 22(9):1214-22. PubMed ID: 27339253
    [Abstract] [Full Text] [Related]

  • 20. Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients.
    Avolio AW, Cillo U, Salizzoni M, De Carlis L, Colledan M, Gerunda GE, Mazzaferro V, Tisone G, Romagnoli R, Caccamo L, Rossi M, Vitale A, Cucchetti A, Lupo L, Gruttadauria S, Nicolotti N, Burra P, Gasbarrini A, Agnes S, Donor-to-Recipient Italian Liver Transplant (D2R-ILTx) Study Group.
    Am J Transplant; 2011 Dec 08; 11(12):2724-36. PubMed ID: 21920017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.